Beth Kelly

Beth Kelly is the Head of Late Stage Immunology at Sanofi, where they are currently leading immunology initiatives. They previously served as a Senior Director at AstraZeneca, focusing on vaccine programs and clinical virology. Earlier in their career, Beth held various scientific roles at MedImmune, Roche, and GlaxoSmithKline, contributing to antiviral drug discovery and assay development. They earned a Ph.D. in Virology & Gene Therapy from the Mayo Clinic Graduate School of Biomedical Sciences and a B.S. in Biology from Syracuse University.